Regeneron Pharmaceuticals (REGN) Total Current Liabilities (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Total Current Liabilities came in at $5.1 billion in Q1 2026, up 43.21% year-on-year from $3.6 billion in Q1 2025, and up 16.92% quarter-over-quarter from $4.4 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Total Current Liabilities for 18 years, with the latest figure at $5.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 43.21% year-over-year to $5.1 billion; the trailing twelve-month figure through Mar 2026 stood at $5.1 billion (up 43.21% YoY), and the FY2025 full-year result was $4.4 billion, up 10.75% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $5.1 billion, up from $4.4 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $5.1 billion in Q1 2026, with the low at $2.9 billion in Q3 2022.
- Average Total Current Liabilities over 5 years is $3.6 billion, with a median of $3.6 billion recorded in 2025.
- Year-over-year, Total Current Liabilities declined 22.49% in 2022 and surged 43.21% in 2026.
- Tracing REGN's Total Current Liabilities over 5 years: stood at $3.1 billion in 2022, then increased by 8.98% to $3.4 billion in 2023, then climbed by 15.22% to $3.9 billion in 2024, then rose by 10.75% to $4.4 billion in 2025, then gained by 16.92% to $5.1 billion in 2026.
- The last three Total Current Liabilities figures came in at $5.1 billion (Q1 2026), $4.4 billion (Q4 2025), and $4.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 289.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 Bn |
| Dec 31, 2025 | 4.37 Bn |
| Sep 30, 2025 | 4.43 Bn |
| Jun 30, 2025 | 3.67 Bn |
| Mar 31, 2025 | 3.57 Bn |
| Dec 31, 2024 | 3.94 Bn |
| Sep 30, 2024 | 3.66 Bn |
| Jun 30, 2024 | 3.51 Bn |
| Mar 31, 2024 | 3.58 Bn |
| Dec 31, 2023 | 3.42 Bn |
| Sep 30, 2023 | 3.60 Bn |
| Jun 30, 2023 | 3.10 Bn |
| Mar 31, 2023 | 3.10 Bn |
| Dec 31, 2022 | 3.14 Bn |
| Sep 30, 2022 | 2.88 Bn |
| Jun 30, 2022 | 3.03 Bn |
| Mar 31, 2022 | 3.01 Bn |
| Dec 31, 2021 | 3.93 Bn |
| Sep 30, 2021 | 3.71 Bn |
| Jun 30, 2021 | 3.73 Bn |
| Mar 31, 2021 | 3.22 Bn |
| Dec 31, 2020 | 2.70 Bn |
| Sep 30, 2020 | 2.34 Bn |
| Jun 30, 2020 | 3.70 Bn |
| Mar 31, 2020 | 2.06 Bn |
| Dec 31, 2019 | 2.10 Bn |
| Sep 30, 2019 | 1.77 Bn |
| Jun 30, 2019 | 1.71 Bn |
| Mar 31, 2019 | 1.51 Bn |
| Dec 31, 2018 | 1.44 Bn |
| Sep 30, 2018 | 1.42 Bn |
| Jun 30, 2018 | 1.33 Bn |
| Mar 31, 2018 | 1.27 Bn |
| Dec 31, 2017 | 1.14 Bn |
| Sep 30, 2017 | 1.14 Bn |
| Jun 30, 2017 | 1.03 Bn |
| Mar 31, 2017 | 1.31 Bn |
| Dec 31, 2016 | 1.24 Bn |
| Sep 30, 2016 | 961.19 Mn |
| Jun 30, 2016 | 951.56 Mn |
| Mar 31, 2016 | 919.72 Mn |
| Dec 31, 2015 | 811.16 Mn |
| Sep 30, 2015 | 734.99 Mn |
| Jun 30, 2015 | 601.54 Mn |
| Mar 31, 2015 | 536.13 Mn |
| Dec 31, 2014 | 654.66 Mn |
| Sep 30, 2014 | 410.20 Mn |
| Jun 30, 2014 | 351.58 Mn |
| Mar 31, 2014 | 305.07 Mn |
| Dec 31, 2013 | 298.84 Mn |
| Sep 30, 2013 | 268.73 Mn |
| Jun 30, 2013 | 203.80 Mn |
| Mar 31, 2013 | 197.24 Mn |
| Dec 31, 2012 | 163.55 Mn |
| Sep 30, 2012 | 178.57 Mn |
| Jun 30, 2012 | 183.22 Mn |
| Mar 31, 2012 | 160.39 Mn |
| Dec 31, 2011 | 148.27 Mn |
| Sep 30, 2011 | 133.24 Mn |
| Jun 30, 2011 | 135.87 Mn |
| Mar 31, 2011 | 112.25 Mn |
| Dec 31, 2010 | 109.06 Mn |
| Sep 30, 2010 | 133.83 Mn |
| Jun 30, 2010 | 119.57 Mn |
| Dec 31, 2009 | 93.58 Mn |